Syneron Medical (NASDAQ: ELOS) reported Q3 EPS of $0.03, in-line with the analyst estimate of $0.03. Revenue for the quarter came in at $62.1 million versus the consensus estimate of $66.6 million.

For earnings history and earnings-related data on Syneron Medical (ELOS) click here.